Mitomycin

In the US, Mitomycin (mitomycin systemic) is a member of the drug class antibiotics/antineoplastics and is used to treat Bladder Cancer, Pancreatic Cancer and Stomach Cancer.

US matches:

• Mitomycin


• Mitomycin Intravenous

UK matches:

• Mitomycin-C Kyowa, 2mg, 10mg, 20mg or 40mg powder for solution for injection. (SPC)

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L01DC03

CAS registry number (Chemical Abstracts Service)

0000050-07-7

Chemical Formula

C15-H18-N4-O5

Molecular Weight

334

Therapeutic Category

Antineoplastic antibacterial

Chemical Names

[(1aS,8S,8aR,8bS)-6-amino-8a-methoxy-5-methyl-4,7-dioxo-1,1a,2,4,7,8,8a,8b-octahydroazirino[2',3':3,4]pyrrolo[1,2-a]indol-8-ylmethyl]carbamate (IUPAC)

6-Amino-1,1a,2,8,8a,8b-hexahydro-8-(hydroxymethyl)-8a-methoxy-5-methylazarino[2',3':3,4]pyrrolo(1,2-a)indole-4,7-dione carbamate (ester) (WHO)

Foreign Names

• Mitomycinum (Latin)
• Mitomycin (German)
• Mitomycine (French)
• Mitomicina (Spanish)

Generic Names

• Mitomicina (OS: DCIT)
• Mitomycin (OS: USAN, BAN)
• Mitomycine (OS: DCF)
• MIT-C (IS)
• Mitomycin (PH: BP 2010, Ph. Eur. 6, USP 32)
• Mitomycin C (PH: JP XIV)
• Mitomycine C (PH: Ph. Franç. Xe édit)
• Mitomycinum (PH: Ph. Eur. 6)

Brand Names

• Amétycine
  Biosyn, Germany; Sanofi Aventis, Tunisia; Sanofi-Aventis, France



• Asomutan
  Raffo, Argentina



• Crisofimina
  Teva, Argentina



• Mitem
  Curasan, Germany; Schwarz, Germany



• Mitocin
  Bristol-Myers Squibb, Brazil; Bristol-Myers Squibb, Mexico



• Mitocyna
  Richmond, Argentina



• Mito-extra
  Medac, Germany



• Mitokebir
  Aspen, Argentina



• Mitolem
  Lemery, Peru



• Mito-medac
  Medac, Germany



• Mitomicina C Dosa
  Dosa, Argentina



• Mitomicina C Filaxis
  Filaxis, Argentina



• Mitomicina C Kyowa
  Kyowa, Myanmar



• Mitomicina C Sandoz
  Sandoz, Argentina



• Mitomicina Delta Farma
  Delta Farma, Argentina



• Mitomicina Farma APS
  Aps, Portugal



• Mitomicina Martian
  LKM, Argentina



• Mitomicina Microsules
  Microsules, Argentina



• Mitomicina Mitolem
  Lemery, Peru



• Mitomicina Rontag
  Rontag, Argentina



• Mitomicina
  Baxter, Chile; Bestpharma, Chile; Kampar, Chile



• Mitomycin C
  Biochem, India; Bristol-Myers Squibb, New Zealand; Inibsa, Spain; Kyowa, Israel; Kyowa, Italy; Kyowa, Poland; Refasa, Peru



• Mitomycin Hexal
  Hexal, Germany



• Mitomycin medac
  Medac, Germany; Medac, Denmark



• Mitomycin
  Accord, United States; Baxter, United States; Bedford, United States; Kyowa Hakko Kirin, Japan; Medac, Sweden; SuperGen, United States



• Mitomycin-C Kyowa
  Bristol-Myers Squibb, Australia; Christiaens, Luxembourg; Ebewe, Austria; Kyowa, Czech Republic; Kyowa, United Kingdom; Kyowa, Georgia; Kyowa, Hong Kong; Kyowa, Hungary; Kyowa, Sri Lanka; Kyowa, Malaysia; Kyowa, Philippines; Kyowa, Singapore; Kyowa, Thailand; Kyowa Hakko, Indonesia; Kyowa Hakko Kogyo, Vietnam; Nycomed, Luxembourg; Nycomed, Netherlands; Onko-Koçsel, Turkey



• Mitomycin-C
  Kuai Kuai, Taiwan; Vianex / BIANEΞ, Greece



• Mitomycine-C
  Nycomed, Belgium



• Mitomycin-Kyowa
  Kyowa, China



• Mitonco
  Korea United Pharm, Georgia



• Mitonovag
  Gobbi, Argentina



• Mitostat
  Orion, Finland



• Mitotie
  Armstrong, Mexico; Bagó, Ecuador; Bioprofarma, Argentina



• Mutamycin
  Bristol-Myers Squibb, Romania; Bristol-Myers Squibb, United States



• Riptam
  Tecnofarma, Peru



• Sintemicina
  Sintesina, Argentina



• Urocin
  Apogepha, Germany



• Vero-Mitomycin
  Verofarm, Russian Federation



• Vetio
  Ivax, Argentina

International Drug Name Search

Glossary

BAN	British Approved Name
DCF	Dénomination Commune Française
DCIT	Denominazione Comune Italiana
IUPAC	International Union of Pure and Applied Chemistry
IS	Inofficial Synonym
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
SPC	Summary of Product Characteristics (UK)
USAN	United States Adopted Name
WHO	World Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.